Authors:
Murata, H
Mattoussi, H
Merritt, CD
Iizumi, Y
Kido, J
Tokuhisa, H
Tsutsui, T
Kafafi, ZH
Citation: H. Murata et al., Molecular organic light-emitting diodes based on a guest-host active layer: Approaches for enhancing device performance, MOLEC CRYST, 353, 2000, pp. 567-580
Citation: Gp. Kushto et al., A matrix-isolation spectroscopic and theoretical investigation of tris(8-hydroxyquinolinato)aluminum(III) and tris(4-methyl-8-hydroxyquinolinato)aluminum(III), J PHYS CH A, 104(16), 2000, pp. 3670-3680
Authors:
Ugawa, T
Kakuta, H
Moritani, H
Matsuda, K
Ishihara, T
Yamaguchi, M
Naganuma, S
Iizumi, Y
Shikama, H
Citation: T. Ugawa et al., YM-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species, BR J PHARM, 131(1), 2000, pp. 63-70
Authors:
Tomura, Y
Tahara, A
Tsukada, J
Yatsu, T
Uchida, W
Iizumi, Y
Honda, K
Citation: Y. Tomura et al., Pharmacological profile of orally administered YM087, a vasopressin antagonist, in conscious rats, CLIN EXP PH, 26(5-6), 1999, pp. 399-403
Authors:
Mattoussi, H
Murata, H
Merritt, CD
Iizumi, Y
Kido, J
Kafafi, ZH
Citation: H. Mattoussi et al., Photoluminescence quantum yield of pure and molecularly doped organic solid films, J APPL PHYS, 86(5), 1999, pp. 2642-2650
Authors:
Yatsu, T
Tomura, Y
Tahara, A
Wada, K
Kusayama, T
Tsukada, J
Tokioka, T
Uchida, W
Inagaki, O
Iizumi, Y
Tanaka, A
Honda, K
Citation: T. Yatsu et al., Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V-1A and V-2 receptor antagonist, in dogs with pacing-induced congestive heart failure, EUR J PHARM, 376(3), 1999, pp. 239-246